연구성과로 돌아가기

2022 연구성과별 연구자 정보 (486 / 2879)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Clinical implication of KRAS mutation variants in patients with resected colon cancer Baek, Jin Ho Baek, JH 1
Clinical implication of KRAS mutation variants in patients with resected colon cancer Kang, Byung Woog Kang, BW 2
Clinical implication of KRAS mutation variants in patients with resected colon cancer Choi, Gyu Seog Choi, GS 3
Clinical implication of KRAS mutation variants in patients with resected colon cancer Kim, Jong Gwang Kim, JG 4 JXL-8219-2024 Kim, Sung-Bae
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Shin, Seung Yong Shin, SY 1 Chung Ang Univ, Dept Internal Med, Coll Med, 102 Heukseok Ro, Seoul 06973, South Korea 0000-0001-8970-2444 Shin, Seung Yong gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Park, Soo Jung Park, SJ 2 Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Park, Soo Jung Park, SJ 2 Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Young Kim, Y 3 Chung Ang Univ, Dept Internal Med, Coll Med, 102 Heukseok Ro, Seoul 06973, South Korea HKV-6163-2023 kim, juhee gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Im, Jong Pil Im, JP 4 Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea 0000-0003-1584-0160 Im, Jong Pil gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Im, Jong Pil Im, JP 4 Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea 0000-0003-1584-0160 Im, Jong Pil gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Hyo Jong Kim, HJ 5 Kyung Hee Univ Hosp, Dept Gastroenterol, Seoul, South Korea AAE-4958-2019 Kim, Jong gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Lee, Kang-Moon Lee, KM 6 Catholic Univ Korea, Dept Gastroenterol, St Vincents Hosp, Suwon, South Korea 0000-0003-2850-4553 Lee, Kang-Moon gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Ji Won Kim, JW 7 Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Ji Won Kim, JW 7 Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Ji Won Kim, JW 7 SMG SNU Boramae Med Ctr, Dept Gastroenterol, Seoul, South Korea gicch@cau.ac.kr;
페이지 이동: